Psoriatic Arthritis. 302

Psoriatic Arthritis

* Study-related phone and in-clinic visits with Physician at no cost

Psoriasis study and treatment

Psoriatic Arthritis

‍

‍

- Participants must be ≥18 years of age at the time of signing the informed consent. - Participants who have a confirmed diagnosis of PsA per the 2006 Classification for Psoriatic Arthritis (CASPAR) criteria with symptoms for ≥6 months before the Screening Visit. - Among others.

- Participants with a known hypersensitivity, or any contraindication, to risankizumab or any of its excipients. - Participants with a known hypersensitivity to sonelokimab or any of its excipients. - Among others.